Research group at the University of Edinburgh using genome editing and targeted protein degradation to study genetic disease and therapy

Joined December 2013
34 Photos and videos
Pinned Tweet
Today in @NatureGenet, we report a saturation genome editing study that systematically dissects the degron of β-Catenin: one of the most frequently mutated regions of the cancer genome. Collab with @kiddevonline and @DeryaDOzdemir, among many others rdcu.be/e1Tvk
1
12
55
6,191
🔬 New lab preprint: How does the mode of oncogene activation shape PROTAC efficacy? Led by Evelina Gudauskaite, we ask whether stabilising mutations vs transcriptional upregulation have distinct consequences for targeted protein degradation. biorxiv.org/content/10.64898….

1
1
2
120
Using a controlled cellular system (dTAG TetOn3G), we found: ✅ Stabilising mutations don’t limit PROTAC action—degradation resets protein levels to the same baseline. ❌ Increased transcription raises target protein levels both pre‑ and post‑treatment.
1
43
This reveals a synthesis‑dependent ceiling on degradation, with implications for: • interpreting preclinical degrader data • resistance mechanisms • genotype‑guided therapy design
20
Andrew Wood retweeted
1/ Happy to share important work done with my co-author Andrew Khalil in the labs of Rudolf Jaenisch @WhiteheadInst @MITBiology @MIT and Dave Mooney @Harvard @wyssinstitute trying to assess and fix the major problem of transgene silencing in human ESC/iPSC based work
5
30
171
87,148
Andrew Wood retweeted
The big one is finally out!! In this paper, we set out to provide insight into the fundamental question; How do the individual cells from complex tissues regulate their proteomes? Brief summary of our findings 👇 biorxiv.org/content/10.1101/…
6
39
199
41,425
Our manuscript characterising tissue-specific consequences of tagged protein fusions in CRISPR-engineered mice is now online @PLOSGenetics. journals.plos.org/plosgeneti…. Thanks again to all coauthors, reviewers and editors for a smooth publication process.
Happy to share our latest work and first manuscript from the Degron Tagging Cluster @MRCMouseNetwork. If you work with protein tags, particularly in tissue biology models, this should be of interest. biorxiv.org/content/10.1101/…
1
2
9
587
Andrew Wood retweeted
Know it before you tag it!! 🏷️🧬
Happy to share our latest work and first manuscript from the Degron Tagging Cluster @MRCMouseNetwork. If you work with protein tags, particularly in tissue biology models, this should be of interest. biorxiv.org/content/10.1101/…
1
3
316
Happy to share our latest work and first manuscript from the Degron Tagging Cluster @MRCMouseNetwork. If you work with protein tags, particularly in tissue biology models, this should be of interest. biorxiv.org/content/10.1101/…

1
1
5
1,100
By surveying a series of CRISPR-engineered mice, we found that tags often change protein expression in some tissues but have little effect, or even opposite effects, in others. Why?
1
2
93
We characterise two underlying mechanisms with opposing effects on protein stability and explain their tissue-specificity, providing a rational basis for improved experimental design. Congrats to 1st author Gillian Taylor and all who contributed. Feedback welcome!
1
84
Andrew Wood retweeted
🚨We are recruiting🚨. We have a @UKRI_News funded position available @mrc_hgu for a Research Assistant working on Polycystic Liver Disease with @scott_wad_dell & @Mill_lab ! If you are interested in #organoids, #singlecell and disease modelling then apply! job: 11386 & link👇
1
12
12
5,596
Andrew Wood retweeted
19 Oct 2023
Excited to share my PhD work, out now in @ScienceMagazine ! What governs successful lysosomal degradation of membrane proteins mediated by extracellular degraders? Can we improve degradation efficacy? science.org/doi/10.1126/scie…🧵(1/n)
13
77
560
142,050
Andrew Wood retweeted
Thrilled to share that, together with my colleagues @UoDCeTPD and collaborators @Boehringer, we report @ScienceMagazine the breakthrough discovery and characterization of a small-molecule that degrades most oncogenic mutant forms of KRAS. 1/8 science.org/doi/10.1126/scie…
15
86
363
45,525